Patents by Inventor Daniel Bast

Daniel Bast has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10130633
    Abstract: The present invention relates to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease such as cancer, wherein i.a.: LA represents an optionally substituted methylene or ethylene group; LB represents —N(H)—C(?O)— or —C(?O)—N(H)—; R1 represents an optionally substituted 5- to 8-membered heterocycloalkyl, 4- to 10-membered heterocycloalkenyl, aryl, heteroaryl or —N(R7)(Ci-C6-alkyl) group; R2 represents an optionally substituted 5- or 6-membered heteroaryl group; R3 represents an optionally substituted phenyl group.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: November 20, 2018
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Kai Thede, William Scott, Eckhard Bender, Stefan Golz, Andrea Hägebarth, Philip Lienau, Florian Puehler, Daniel Basting, Dirk Schneider, Manfred Möwes, Anja Richter, Ludwig Zorn, Ningshu Liu, Ursula Mönning, Franziska Siegel
  • Patent number: 9884063
    Abstract: The present invention relates to amido-substituted azole compounds of general formula (I), in which X1, X2, R1, R2, R4, R5, R7 and R8 are as defined in the claims which are inhibitors of TNKS1 and/or TNKS2, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: February 6, 2018
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Knut Eis, Jens Ackerstaff, Sarah Wagner, Daniel Basting, Stefan Golz, Eckhard Bender, Volkhart Min-Jian Li, Philip Lienau, Ningshu Liu, Franziska Siegel, Marcus Bauser, Detlev Sülzle, Simon Holton, Michaela Bairlein, Philipp Buchgraber, József Bálint
  • Patent number: 8332018
    Abstract: A method, a system and an arrangement to predict at least one system event and a corresponding computer program and a corresponding machine-readable storage medium are configured so that the event is predictable because of trends in observables over a certain period before the occurrence of the events. The method, system and arrangement can be used in particular for patient-specific monitoring of patho-physiological changes but also in geophysical or abstract units such as population or economic systems in which the deviation from a defined normal condition is predicted.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: December 11, 2012
    Assignee: BIOTRONIK CRM Patent AG
    Inventors: Manuel Ebert, Daniel Bast, Thomas Kraemer, Sergey Berdyshev, Wolfgang Meyer
  • Publication number: 20100262027
    Abstract: A method, a system and an arrangement to predict at least one system event and a corresponding computer program and a corresponding machine-readable storage medium are configured so that the event is predictable because of trends in observables over a certain period before the occurrence of the events. The method, system and arrangement can be used in particular for patient-specific monitoring of patho-physiological changes but also in geophysical or abstract units such as population or economic systems in which the deviation from a defined normal condition is predicted.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 14, 2010
    Applicant: BIOTRONIK CRM PATENT AG
    Inventors: Manuel Ebert, Daniel Bast, Thomas Krämer, Sergey Berdyshev, Wolfgang Meyer